Nicolas Tsavaris

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Kosmas C; Mylonakis N; Tsakonas G; Vorgias G; Karvounis N; Tsavaris N; Daladimos T; Kalinoglou N; Malamos N; Akrivos T; Karabelis A
Evaluation of the paclitaxel-ifosfamide-cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer.
Polyzos Aristides; Gogas Helen; Markopoulos Christos; Tsavaris Nikolas; Papadopoulos Othon; Polyzos Kostas; Giannopoulos Athanasios
Salvage chemotherapy with oxaliplatin and capecitabine for breast cancer patients pretreated with anthracyclines and taxanes.
Polyzos Aristides; Tsavaris Nikolas; Gogas Helen; Lagadas Antonios; Polyzos Kostas; Giannakopoulos Kostas; Felekouras Evangelos; Tsigris Christos; Karatzas Theodoros; Papadopoulos Othon; Giannopoulos Athanasios
Cisplatin-Ifosfamide-gemcitabine as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and Paclitaxel.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Nicolas Tsavaris (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Kosmas C; Mylonakis N; Tsakonas G; Vorgias G; Karvounis N; Tsavaris N; Daladimos T; Kalinoglou N; Malamos N; Akrivos T; Karabelis A
Evaluation of the paclitaxel-ifosfamide-cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer.
British journal of cancer 2009;101(7):1059-65.
2009: Polyzos Aristides; Gogas Helen; Markopoulos Christos; Tsavaris Nikolas; Papadopoulos Othon; Polyzos Kostas; Giannopoulos Athanasios
Salvage chemotherapy with oxaliplatin and capecitabine for breast cancer patients pretreated with anthracyclines and taxanes.
Anticancer research 2009;29(7):2851-6.
2009: Polyzos Aristides; Tsavaris Nikolas; Gogas Helen; Lagadas Antonios; Polyzos Kostas; Giannakopoulos Kostas; Felekouras Evangelos; Tsigris Christos; Karatzas Theodoros; Papadopoulos Othon; Giannopoulos Athanasios
Cisplatin-Ifosfamide-gemcitabine as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and Paclitaxel.
Anticancer research 2009;29(7):2681-6.
2009: Tsavaris Nicolas; Lazaris Andreas; Kosmas Christos; Gouveris Panagiotis; Kavantzas Nikolaos; Kopterides Petros; Papathomas Thomas; Agrogiannis George; Zorzos Haralambos; Kyriakou Vassiliki; Patsouris Efstratios;
Topoisomerase I and IIalpha protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy.
Cancer chemotherapy and pharmacology 2009;64(2):391-8.
2009: Tsavaris Nikolas; Kavantzas Nicolaos; Tsigritis Kostantinos; Xynos Ioannis D; Papadoniou Nikitas; Lazaris Andreas; Kosmas Christos; Agrogiannis George; Dokou Anna; Felekouras Evangelos; Antoniou Efstathios; Polyzos Aris; Sarantonis John; Tsipras Heracles; Karatzas Gavrilos; Papalambros Alexandros; Patsouris Efstratios S
Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
BMC cancer 2009;9():264.
2008: Tsavaris Nicolas; Kopterides Petros; Kosmas Christos; Efthymiou Athina; Skopelitis Hlias; Dimitrakopoulos Antonios; Pagouni Eyterpi; Pikazis Dimitrios; Zis Panagiotis-Vasilis; Koufos Christos
Gabapentin monotherapy for the treatment of chemotherapy-induced neuropathic pain: a pilot study.
Pain medicine (Malden, Mass.) 2008;9(8):1209-16.
2008: Tsavaris N; Kosmas C; Kopterides P; Vadiaka M; Kosmas N; Skopelitis H; Karadima D; Kolliokosta G; Tzima E; Loukeris D; Pagouni E; Batziou E; Xyla V; Koufos C
Efficacy of tropisetron in patients with advanced non-small-cell lung cancer receiving adjuvant chemotherapy with carboplatin and taxanes.
European journal of cancer care 2008;17(2):167-73.
2008: Papadoniou Nikitas; Kosmas Christos; Gennatas Kostadinos; Polyzos Aris; Mouratidou Despina; Skopelitis Elias; Tzivras Michalis; Sougioultzis Stavros; Papastratis George; Karatzas Gavrilos; Papalambros Efstathios; Tsavaris Nikolas
Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
Anticancer research 2008;28(1B):543-9.
2008: Kosmas Christos; Kallistratos Manolis S; Kopterides Petros; Syrios John; Skopelitis Helias; Mylonakis Nicolaos; Karabelis Athanasios; Tsavaris Nicolas
Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study.
Journal of cancer research and clinical oncology 2008;134(1):75-82.
2007: Kopterides Petros; Mourtzoukou Eleni G; Skopelitis Elias; Tsavaris Nicolas; Falagas Matthew E
Aspects of the association between leishmaniasis and malignant disorders.
Transactions of the Royal Society of Tropical Medicine and Hygiene 2007;101(12):1181-9.
2007: Gouveris P; Lazaris A C; Papathomas T G; Nonni A; Kyriakou V; Delladetsima J; Patsouris E S; Tsavaris N
Topoisomerase I protein expression in primary colorectal cancer and recurrences after 5-FU-based adjuvant chemotherapy.
Journal of cancer research and clinical oncology 2007;133(12):1011-5.
2007: Kosmas Christos; Tsavaris Nicolas; Malamos Nikolaos; Tsakonas George; Gassiamis Argyris; Polyzos Aristidis; Mylonakis Nicolas; Karabelis Athanasios
Docetaxel-ifosfamide combination in patients with HER2-non-overexpressing advanced breast cancer failing prior anthracyclines.
Investigational new drugs 2007;25(5):463-70.
2007: Tsavaris Nicolas; Mavragani Clio P; Pikazis Dimitrios;
Rheumatoid arthritis: correlation between rheumatoid factor levels and CA-125 tumour marker elevation.
Annals of the rheumatic diseases 2007;66(7):980.
2007: Kosmas C; Tsavaris N; Mylonakis N; Tsakonas G; Gassiamis A; Skopelitis H; Polyzos A; Malamos N; Karabelis A
Docetaxel-ifosfamide combination in patients with advanced breast cancer failing prior anthracycline-based regimens: results of a phase I-II study.
Journal of chemotherapy (Florence, Italy) 2007;19(3):322-31.
2007: Polyzos Aristides; Kosmas Christos; Tsavaris Nikolas; Toufexi Helen; Lagadas Antonios; Gogas Helen; Giannakopoulos Kostas; Kouraklis Gregory; Griniatsos John; Felekouras Evagelos; Tsigris Christos; Nikiteas Nikolas; Papadopoulos Othon; Giannopoulos Athanasios
Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel.
Anticancer research 2007;27(3B):1645-51.
2007: Mouratidou D; Gennatas C; Michalaki V; Papadimitriou A; Andreadis C H; Sykiotis C; Tsavaris N
A phase III randomized study comparing paclitaxel and cisplatin versus cyclophosphamide and cisplatin in patients with advanced ovarian cancer.
Anticancer research 2007;27(1B):681-5.
2007: Kosmas Christos; Tsavaris Nicolas; Syrigos Konstantinos; Koutras Angelos; Tsakonas George; Makatsoris Thomas; Mylonakis Nicolas; Karabelis Athanasios; Stathopoulos George P; Kalofonos Haralambos P
A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens.
Cancer chemotherapy and pharmacology 2007;59(1):51-9.
2007: Sipsas Nikolaos V; Kosmas Christos; Ziakas Panayiotis D; Karabelis Athanasios; Vadiaka Maria; Skopelitis Elias; Kordossis Theodore; Tsavaris Nikolaos
Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate.
Scandinavian journal of infectious diseases 2007;39(9):786-91.
2007: Tsavaris Nicolas; Kosmas Christos; Skopelitis Helias; Papadoniou Nicitas; Polyzos Aristidis; Zografos George; Adoniou Efstathios; Gryniatsos John; Felekouras Evangelos; Zacharakis Michalis; Sigala Francheska; Bacoyiannis Christos; Papastratis George; Papalambros Efstathios
Sequential administration of 5-fluorouracil (5FU)/leucovorin (LV) followed by irinotecan (CPT-11) at relapse versus CPT-11 followed by 5-FU/LV in advanced colorectal carcinoma. A phase III randomized study.
Chemotherapy 2007;53(4):282-91.
2006: Kosmas Christos; Tsavaris Nicolas
A simplified premedication protocol for one-hour paclitaxel infusion in various combinations.
Medical science monitor : international medical journal of experimental and clinical research 2006;12(11):CR462-6.
2006: Gennatas C; Papaxoinis G; Michalaki V; Mouratidou D; Andreadis C; Tsavaris N; Pafiti A
A prospective randomized study of irinotecan (CPT-11), leucovorin (LV) and 5-fluorouracil (5FU) versus leucovorin and 5-fluorouracil in patients with advanced colorectal carcinoma.
Journal of chemotherapy (Florence, Italy) 2006;18(5):538-44.
2006: Bonovas Stefanos; Filioussi Kalitsa; Tsavaris Nikolaos; Sitaras Nikolaos M
Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(30):4808-17.
2006: Tsavaris Nicolas; Kopterides Petros; Kosmas Christos; Vadiaka Maria; Dimitrakopoulos Antonios; Scopelitis Helias; Tenta Roxanni; Vaiopoulos George; Koufos Christos
Analgesic activity of high-dose intravenous calcitonin in cancer patients with bone metastases.
Oncology reports 2006;16(4):871-5.
2006: Polyzos Aristides; Tsavaris Nikolas; Kosmas Christos; Polyzos Kostas; Giannopoulos Athanasios; Felekouras Evangelos; Nikiteas Nikolas; Kouraklis Gregory; Griniatsos John; Safioleas Michael; Stamatakos Michael; Pikoulis Emmanuel; Papachristodoulou Antonios; Gogas Helen
Subsets of patients with advanced gastric cancer responding to second-line chemotherapy with docetaxel-cisplatin.
Anticancer research 2006;26(5B):3749-53.
2006: Gennatas Constantine; Michalaki Vasiliki; Mouratidou Despina; Tsavaris Nikolaos; Andreadis Charalambos; Photopoulos Alexios; Voros Dionysios;
Gemcitabine combined with 5-fluorouracil for the treatment of advanced carcinoma of the pancreas.
In vivo (Athens, Greece) 2006;20(2):301-5.
2006: Tsavaris Nicolas; Kopterides Petros; Kosmas Christos; Siakantaris Marina; Patsouris Evangelos; Pangalis Gerasimos
Spontaneous remission of acute myeloid leukemia associated with GnRH agonist treatment.
Leukemia & lymphoma 2006;47(3):557-60.
2006: Gennatas Constantine; Michalaki Vasiliki; Mouratidou Despina; Tsavaris Nikolaos; Andreadis Charalambos; Psychogios John; Poulakaki Nikiforita
Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancer.
Anticancer research 2006;26(1B):549-52.
2006: Gennatas Constantine; Michalaki Vasiliki; Carvounis Eleni; Psychogios John; Poulakaki Nikiforita; Katsiamis George; Voros Dionysios; Kouloulias Vasilis; Mouratidou Despina; Tsavaris Nikolaos
Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on letrozole or anastrozole. A phase II trial conducted by the Hellenic Group of Oncology (HELGO).
Tumori 2006;92(1):13-7.
2005: Tsavaris Nicolas; Kosmas Christos; Kopterides Petros; Tsikalakis Dimitrios; Skopelitis Hlias; Sakelaridi Fotini; Papadoniou Nikitas; Tzivras Michalis; Balatsos Vasilios; Koufos Christos; Archimandritis Athanasios
Retinol-binding protein, acute phase reactants and Helicobacter pylori infection in patients with gastric adenocarcinoma.
World journal of gastroenterology : WJG 2005;11(45):7174-8.
2005: Bonovas Stefanos; Filioussi Kalitsa; Tsavaris Nikolaos; Sitaras Nikolaos M
Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8606-12.
2005: Tsavaris Nicolas; Kosmas Christos; Skopelitis Elias; Gennatas Kostantinos; Zorbala Alexandra; Papas Paris; Gouveris Panagiotis; Antypas George; Rokana Sofia; Tzelepis George
A phase II study of the docetaxel-carboplatin chemotherapy regimen in advanced non-small-cell lung cancer.
Lung 2005;183(6):405-16.
2005: Tsavaris N; Kosmas C; Skopelitis H; Dimitrakopoulos A; Kopterides P; Bougas D; Stravodimos K; Mitropoulos D; Alamanis C; Giannopoulos A
Methotrexate-paclitaxel-epirubicin-carboplatin (M-TEC) combination chemotherapy in patients with advanced bladder cancer: an open label phase II study.
Journal of chemotherapy (Florence, Italy) 2005;17(4):441-8.
2005: Kosmas Christos; Tsavaris Nicolas B; Tsakonas George; Soukouli Georgia; Gassiamis Argyris; Mylonakis Nicolas; Karabelis Athanasios
Cerebrospinal fluid tumor marker levels in predicting response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.
Medical science monitor : international medical journal of experimental and clinical research 2005;11(8):CR398-401.
2005: Tsavaris Nicolas; Kosmas Christos; Skopelitis Helias; Gouveris Panagiotis; Kopterides Petros; Loukeris Dioynissis; Sigala Frantzeska; Zorbala-Sypsa Alexandra; Felekouras Evangelos; Papalambros Efstathios
Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study.
Investigational new drugs 2005;23(4):369-75.
2005: Polyzos A; Tsavaris N; Vafiadis I; Polyzos K; Griniatsos J; Felekouras E; Nikiteas N I; Halikias S; Nikou G
Phase II study of gemcitabine plus 5-fluorouracil biologically modulated by folinic acid plus long-acting formulation of octreotide (LAR) in patients with advanced pancreatic cancer.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2005;10(3):357-64.
2005: Cosmas C; Tsavaris N; Malamos N; Tsakonas G; Gassiamis A; Skopelitis H; Soukouli G; Polyzos A; Mylonakis N; Karabelis A
Dose escalation of docetaxel and ifosfamide in patients with advanced breast cancer failing prior anthracyclines: mature results of a phase I-II study.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2005;10(3):337-46.
2005: Papalambros E; Felekouras E; Karavokyros I G; Diamantis T; Androulaki A; Boutsis D; Sigala F; Tsavaris N; Pangalis G
Acute abdomen as initial manifestation of M4 - acute non-lymphocytic leukemia.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2005;10(2):277-80.
2005: Tsavaris N; Kosmas C; Vadiaka M; Skopelitis E; Kopteridis P; Pamouki S; Efremidis M; Kasparian H; Moisakis I; Sakelariou D; Koufos C
5-fluorouracil cardiotoxicity is a rare, dose and schedule-dependent adverse event: a prospective study.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2005;10(2):205-11.
2005: Tsavaris N; Kosmas C; Kavantzas N; Lazaris A; Skopelitis E; Dimitrakopoulos A; Siakantaris M P; Papalambros E; Diamantis N; Patsouris E; Pangalis G A
Breast cancer following curative chemotherapy for non-Hodgkin's lymphoma and the effect of drug resistance proteins to the final outcome. A retrospective study.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2005;10(1):71-6.
2005: Tsavaris Nicolas; Kosmas Christos; Vadiaka Maria
A simplified premedication schedule for 1-hour paclitaxel administration.
The journal of supportive oncology 2005;3(1):77-81.
2005: Kosmas Christos; Tsavaris Nicolas; Koutras Aggelos; Makatsoris Thomas; Mylonakis Nicolas; Tzelepis George; Dimitrakopoulos Antonis; Spyropoulos Konstantinos; Polyzos Aristidis; Karabelis Athanasios; Kalofonos Haralambos P
A phase II study of the docetaxel-ifosfamide-carboplatin combination in advanced non-small-cell lung cancer.
Oncology 2005;69(4):333-41.
2005: Kosmas Christos; Tsavaris Nicolas B; Soukouli Georgia; Gouveris Panagiotis; Tsakonas George; Katselis John; Alexopoulos Heraklis; Mylonakis Nicolas; Karabelis Athanasios
Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.
Medical oncology (Northwood, London, England) 2005;22(2):123-8.
2004: Tsavaris N; Gennatas K; Kosmas C; Skopelitis H M; Gouveris P; Dimitrakopoulos A; Zacharakis M; Kouraklis G; Vasiliou J; Felekouras E; Voros D; Zografos G; Balafouta M; Paraskevaidis M; Safioleas M; Fotiadis K; Papastratis G; Karatzas G; Papalambros E
Leucovorin and fluorouracil vs levamisole and fluorouracil as adjuvant chemotherapy in rectal cancer.
Oncology reports 2004;12(4):927-32.
2004: Kopterides Petros; Tsavaris Nikolas; Tzioufas Athanasios; Pikazis Dimitrios; Lazaris Andreas
Digital gangrene and Raynaud's phenomenon as complications of lung adenocarcinoma.
The lancet oncology 2004;5(9):549.
2004: Tsavaris N; Kosmas C; Zorzos H; Lazaris A; Vadiaka M; Dimitrakopoulos A; Siakantaris M P; Rokana S; Papalambros E; Pangalis G A; Davaris P
Breast cancer after curative chemotherapy in non-Hodgkin's lymphoma: examination of the role of drug resistance and retrospective comparison to the outcome of de novo breast cancer.
Oncology reports 2004;11(4):899-903.
2004: Tsavaris Nikolas; Kosmas Christos; Gouveris Panagiotis; Gennatas Kostadinos; Polyzos Aris; Mouratidou Despina; Tsipras Heracles; Margaris Helias; Papastratis George; Tzima Evanthia; Papadoniou Nikitas; Karatzas Gavrilos; Papalambros Efstathios
Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer.
Investigational new drugs 2004;22(2):193-8.
2004: Tsavaris Nicolas; Kosmas Christos; Gouveris Panagiotis; Vadiak Maria; Dimitrakopoulos Antonis; Karadima Dimitra; Pagouni Efterpi; Panagiotakopoulos George; Tzima Evanthia; Ispoglou Sevasti; Sakelariou Dimitris; Koufos Christos
G-CSF in solid tumor chemotherapy: a tailored regimen reduces febrile neutropenia, treatment delays and direct costs.
Medical science monitor : international medical journal of experimental and clinical research 2004;10(2):PI24-8.
2004: Polyzos Aristides; Tsavaris Nicholas; Kosmas Christos; Gogas Helen; Koutinos George; Nikiteas Nicholas I; Felekouras Evangelos; Kouraklis Gregory; Papadopoulos Othon; Papachristodoulou Antonios; Stamatiadis Demetrios; Safioleas Michael; Nikou George
Weekly Gemcitabine plus Fluorouracil-Folinic Acid Given Weekly for Two Days in Patients with Advanced Pancreatic Cancer : A Phase II Study.
Clinical drug investigation 2004;24(11):661-70.
2004: Tsavaris Nick B; Katsoulas Haralabos L; Kosmas Christos; Papalambros Efstathios; Gouveris Panayiotis; Papantoniou Nikitas; Rokana Sophia; Kosmas Nicolaos; Skopeliti Margarita; Tsitsilonis Ourania E
The effect of Edrecolomab (Mo17-1A) or fluorouracil-based chemotherapy on specific immune parameters in patients with colorectal cancer. A comparative study.
Oncology 2004;67(5-6):403-10.
2003: Polyzos A; Tsavaris N; Kosmas C; Gogas H; Toufexi H; Kosmidis C; Markopoulos C; Giannopoulos A; Papadopoulos O; Stamatiadis D; Kouraklis G
Full dose paclitaxel plus vinorelbine as salvage chemotherapy in anthracycline-resistant advanced breast cancer: a phase II study.
Journal of chemotherapy (Florence, Italy) 2003;15(6):607-12.
2003: Tsavaris N; Ziras N; Kosmas C; Giannakakis T; Gouveris P; Vadiaka M; Dimitrakopoulos A; Karadima D; Rokana S; Papalambros E; Papastratis G; Margaris H; Tsipras H; Polyzos A
Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized study.
Cancer chemotherapy and pharmacology 2003;52(6):514-9.
2003: Sotiropoulou Panagiota A; Perez Sonia A; Voelter Volfgang; Echner Hartmut; Missitzis Ioannis; Tsavaris Nick B; Papamichail Michael; Baxevanis Constantin N
Natural CD8+ T-cell responses against MHC class I epitopes of the HER-2/ neu oncoprotein in patients with epithelial tumors.
Cancer immunology, immunotherapy : CII 2003;52(12):771-9.
2003: Kopterides Petros; Halikias Spyridon; Tsavaris Nikolaos
Visceral leishmaniasis masquerading as myelodysplasia.
American journal of hematology 2003;74(3):198-9.
2003: Tsavaris Nicolas; Kosmas Christos; Vadiaka Maria; Zonios Dimitris; Papalambros Efstathios; Papantoniou Nikitas; Margaris Heraklis; Zografos George; Rokana Sofia; Retalis George; Koufos Christos
Amifostine, in a reduced dose, protects against severe diarrhea associated with weekly fluorouracil and folinic acid chemotherapy in advanced colorectal cancer: a pilot study.
Journal of pain and symptom management 2003;26(3):849-54.
2003: Tsitsilonis O E; Tsavaris N B; Kosmas C; Gouveris P; Papalambros E
Immune changes in patients with colorectal cancer treated by adjuvant therapy with monoclonal antibody 17-1A: a pilot study.
Journal of chemotherapy (Florence, Italy) 2003;15(4):387-93.
2003: Polyzos Aristides; Tsavaris Nicholas; Kosmas Christos; Gogas Helen; Vadiaka Maria; Markopoulos Christos; Giannopoulos Athanasios; Kalahanis Nicholas; Stamatiadis Demetrios; Kouraklis Gregory; Karatzas Gabriel; Liapis Christos; Syrigos Konstantinos
Docetaxel and epirubicin supported by granulocyte colony-stimulating factor first-line in advanced breast cancer.
Anticancer research 2003;23(3C):2917-23.
2003: Kosmas C; Tsavaris N; Malamos N; Stavroyianni N; Gregoriou A; Rokana S; Polyzos A
Phase I-II study of docetaxel and ifosfamide combination in patients with anthracycline pretreated advanced breast cancer.
British journal of cancer 2003;88(8):1168-74.
2003: Kosmas Christos; Tsavaris Nicolas; Mylonakis Nicolas; Kalofonos Haralambos P
An overview of current results with the gemcitabine and docetaxel combination as initial and salvage chemotherapy regimen in advanced non-small cell lung cancer.
Critical reviews in oncology/hematology 2003;45(3):265-75.
2003: Gennatas C; Dardoufas C; Mouratidou D; Tsavaris N; Pouli A; Androulakis G; Philippakis M; Voros D; Batalis T; Besbeas S; Hatzistylianos G; Katsos J; Komporozos V; Legakis N; Mallas H; Peros G; Photopoulos A; Pisiotis C; Polymeneas G; Retalis G; Samanidis L; Smyrniotis V; Stamatiadis A; Vasiliou J; Andreadis H; Papadimitriou J
Surgical adjuvant therapy of rectal carcinoma: a controlled evaluation of leucovorin, 5-fluorouracil and radiation therapy with or without interferon-alpha2b.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(3):378-82.
2003: Skopelitis E; Panayiotakopoulos G D; Kontos A N; Androulaki A; Hatzianastassiou D; Hatzimanolis E; Tsavaris N; Kordossis T
Sequential development of triple malignancy in an HIV-positive patient.
Journal of chemotherapy (Florence, Italy) 2003;15(1):97-8.
2002: Sipsas N V; Kontos A; Panayiotakopoulos G D; Androulaki A; Zormpala A; Balafouta M E; Dounis E; Tsavaris N; Kordossis T
Extranodal non-Hodgkin lymphoma presenting as a soft tissue mass in the proximal femur in a HIV(+) patient.
Leukemia & lymphoma 2002;43(12):2405-7.
2002: Kosmas C; Malamos N A; Stefanou S; Gregoriou A; Tsavaris N
Intramedullary spinal cord metastases in breast carcinoma: report of two cases and review of the literature.
Journal of chemotherapy (Florence, Italy) 2002;14(6):631-4.
2002: Tsavaris Nicolas; Kosmas Christos; Gennatas Kostas; Vadiaka Maria; Paliaros Platon; Dimitrakopoulos Antonis; Diamantis Theodoros; Tsipras Heraklis; Papastratis George
Etoposide added to weekly leucovorin (LV)/5-fluorouracil (5-FU) in LV/5-FU pre-treated patients with advanced colorectal cancer.
Medical science monitor : international medical journal of experimental and clinical research 2002;8(9):PI65-9.
2002: Tsavaris N; Kosmas C; Gennatas K; Vadiaka M; Skopelitis E; Xila V; Rokana S; Margaris E; Zografos G; Papastratis G; Kouraklis G
Etoposide, leucovorin (LV) and 5-fluorouracil (5-FU) in 5-FU+LV pre-treated patients with advanced colorectal cancer.
Journal of chemotherapy (Florence, Italy) 2002;14(4):406-11.
2002: Tsavaris N; Kosmas C; Vadiaka M; Kanelopoulos P; Boulamatsis D
Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes.
British journal of cancer 2002;87(1):21-7.
2002: Kosmas Christos; Tsavaris Nicolas; Kalofonos Haralambos P
Salvage chemotherapy with the gemcitabine/docetaxel combination in non-small cell lung cancer: an overview of recent phase II studies.
Medical science monitor : international medical journal of experimental and clinical research 2002;8(6):PI58-63.
2002: Tsavaris Nicolas; Kosmas Christos; Vadiaka Maria; Efremidis Michalis; Zinelis Andreas; Beldecos Dimitris; Sakelariou Dimitris; Koufos Christos; Stamatelos George
Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
Medical science monitor : international medical journal of experimental and clinical research 2002;8(6):PI51-7.
2002: Tsavaris Nikolas; Kosmas Christos; Vadiaka Maria; Giannouli Stavroula; Siakantaris Marina P; Vassilakopoulos Theodoros; Pangalis Gerassimos A
Pegylated liposomal doxorubicin in the CHOP regimen for older patients with aggressive (stages III/IV) non-Hodgkin's lymphoma.
Anticancer research 2002;22(3):1845-8.
2002: Tsavaris N B; Polyzos A; Gennatas K; Kosmas Ch; Vadiaka M; Dimitrakopoulos A; Macheras A; Papastratis G; Tsipras H; Margaris H; Papalambros E; Giannopoulos A; Koufos Ch
Irinotecan (CPT-11) in patients with advanced colon carcinoma relapsing after 5-fluorouracil-leucovorin combination.
Chemotherapy 2002;48(2):94-9.
2002: Kosmas Christos; Tsavaris Nicolas B; Makatsoris Thomas; Onyenadum Adimchi; Vadiaka Maria; Stavroyianni Niki; Sepsas Evangelos; Dimitropoulos Dimitris; Rokana Sofia; Kalofonos Haralambos P
A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer.
International journal of cancer. Journal international du cancer 2002;98(1):141-7.
2002: Kosmas Christos; Malamos Nikolaos A; Tsavaris Nicolas B; Stamataki Melina; Stefanou Stefanos; Gregoriou Achilleas; Rokana Sofia; Vartholomeou Maria; Antonopoulos Minas J
Leptomeningeal carcinomatosis after major remission to taxane-based front-line therapy in patients with advanced breast cancer.
Journal of neuro-oncology 2002;56(3):265-73.
2002: Tsavaris N; Kosmas C; Vadiaka M; Kontos A; Fotia M; Angelopoulou A; Vrizidis N; Soulla M; Sougioultzis S; Koufos Ch
Raltitrexed (tomudex) administration in patients failing multiple prior chemotherapy regimens in advanced colorectal cancer: a pilot study.
Investigational new drugs 2002;20(1):133-6.
2002: Tsavaris N; Karargyris G; Pikazis D; Vadiaka M; Kosmas C; Sakellaropoulos N; Vaiopoulos G
Adenocarcinoma of the colon presenting as polymyositis: case report.
Journal of chemotherapy (Florence, Italy) 2002;14(1):102-5.
2002: Kosmas Christos; Malamos Nikolaos A; Tsavaris Nikolas B; Stamataki Melina; Gregoriou Achilleas; Rokana Sofia; Vartholomeou Maria; Antonopoulos Minas J
Isolated leptomeningeal carcinomatosis (carcinomatous meningitis) after taxane-induced major remission in patients with advanced breast cancer.
Oncology 2002;63(1):6-15.
2002: Tsavaris Nicolas; Kosmas Christos; Vadiaka Maria; Koufos Christos
Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy.
BMC cancer 2002;2():2.
2001: Tsavaris N; Kosmas C; Vadiaka M; Sougioultzis S; Kontos A; Agelopoulou A; Boulamatsis D; Koufos C
Comparative study of tropisetron with the addition of dexamethasone or alprazolam in breast cancer patients receiving adjuvant chemotherapy with CEF (cyclophosphamide, epirubicin and 5-fluorouracil).
Journal of chemotherapy (Florence, Italy) 2001;13(6):641-7.
2001: Kosmas C; Tsavaris N; Vadiaka M; Stavroyianni N; Koutras A; Malamos N; Onyenadum A; Rokana S; Polyzos A; Kalofonos H P
Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.
Cancer 2001;92(11):2902-10.
2001: Tsavaris N; Kosmas C; Polyzos A; Genatas K; Vadiaka M; Paliaros P; Dimitrakopoulos A; Rokana S; Karatzas G; Vachiotis P; Fotiadis K
Leucovorin + 5-fluorouracil plus dipyridamole in leucovorin + 5-fluorouracil-pretreated patients with advanced colorectal cancer: a pilot study of three different dipyridamole regimens.
Tumori 2001;87(5):303-7.
2001: Kosmas C; Tsavaris N; Panopoulos C; Vadiaka M; Stavroyianni N; Kourelis T; Malamos N; Antonopoulos M; Kalofonos H P
Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens.
European journal of cancer (Oxford, England : 1990) 2001;37(8):972-8.
2001: Tsavaris N; Kosmas C H; Vadiaka M; Kontos A; Katsorida M; Dimitrakopoulos A; Zerai A; Koufos C H
Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study.
Journal of experimental & clinical cancer research : CR 2001;20(1):29-34.
2001: Stathopoulos G P; Mavroudis D; Tsavaris N; Kouroussis C; Aravantinos G; Agelaki S; Kakolyris S; Rigatos S K; Karabekios S; Georgoulias V
Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(1):101-3.
2001: Kosmas C; Tsavaris N B; Malamos N A; Vadiaka M; Koufos C
Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):119-26.
2001: Kosmas C; Tsavaris N B; Vadiaka M; Chiras T; Boletis J; Kostakis A
Extragonadal seminoma after renal transplantation and immunosuppression; treatment in the presence of renal dysfunction: a case report and literature review.
Medical oncology (Northwood, London, England) 2001;18(3):221-5.
2001: Polyzos A; Tsavaris N; Kosmas C; Arnaouti T; Kalahanis N; Tsigris C; Giannopoulos A; Karatzas G; Giannikos L; Sfikakis P P
Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience.
Oncology 2001;61(2):129-33.
2000: Tsavaris N; Kosmas C; Mylonakis N; Bacoyiannis C; Kalergis G; Vadiaka M; Boulamatsis D; Iakovidis V; Kosmidis P
Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy.
Anticancer research 2000;20(6C):4777-83.
2000: Mavroudis D; Alexopoulos A; Ziras N; Malamos N; Kouroussis C; Kakolyris S; Agelaki S; Kalbakis K; Tsavaris N; Potamianou A; Rigatos G; Georgoulias V
Front-line treatment of advanced breast cancer with docetaxel and epirubicin: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(10):1249-54.
2000: Tsavaris N; Kosmas C; Vadiaka M; Kanelopoulos P; Kontos A; Katsorida M; Agelopoulou A; Vrizidis N; Fotia M; Papoutsis K; Koufos C
Ondansentron and dexamethasone treatment with different dosing schedules (24 versus 32 mg) in patients with non-small-cell lung cancer under cisplatin-based chemotherapy: a randomized study.
Chemotherapy 2000;46(5):364-70.
2000: Tsavaris N; Skarlos D; Bacoyiannis C; Aravantinos G; Kosmas C; Retalis G; Panopoulos C; Vadiaka M; Dimitrakopoulos A; Kostantinidis K; Mitropoulos D; Bougas D; Pantazopoulos D; Kosmidis P
Combined treatment with low-dose interferon plus vinblastine is associated with less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2000;20(8):685-90.
2000: Kosmas C; Tsavaris N B; Polyzos A; Kalofonos H P; Sepsas E; Malamos N A; Vadiaka M; Dosios T; Antonopoulos M J
A phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma.
Cancer 2000;89(4):774-82.
2000: Kosmas C; Malamos N A; Tsavaris N; Antonopoulos M
Chemotherapy-induced complete regression of choroidal metastases and subsequent isolated leptomeningeal carcinomatosis in advanced breast cancer: a case report and literature review.
Journal of neuro-oncology 2000;47(2):161-5.
2000: Kosmas C; Tsavaris N B; Polyzos A; Malamos N A; Katsikas M; Antonopoulos M J
Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours.
British journal of cancer 2000;82(2):300-7.
1999: Tsavaris N B; Koufos C; Katsikas M; Dimitrakopoulos A; Athanasiou E; Linardaki G
Antiemetic prophylaxis with ondansetron and methylprednisolone vs metoclopramide and methylprednisolone in mild and moderately emetogenic chemotherapy.
Journal of pain and symptom management 1999;18(3):218-22.
1999: Androulakis N; Kourousis C; Dimopoulos M A; Samelis G; Kakolyris S; Tsavaris N; Genatas K; Aravantinos G; Papadimitriou C; Karabekios S; Stathopoulos G P; Georgoulias V
Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(6):1779-85.
1999: Polyzos A; Tsavaris N; Kosmas C; Petrikos G; Giannikos L; Kalahanis N; Papadopoulos O; Christodoulou K; Giannakopoulos K; Veslemes M; Katsilambros N
Second-line chemotherapy with cisplatin-ifosfamide in patients with ovarian cancer previously treated with carboplatin-cyclophosphamide.
Journal of chemotherapy (Florence, Italy) 1999;11(2):144-9.
1999: Sipsas N V; Aroni K; Tsavaris N; Mavragani K; Paikos S; Kordossis T
AIDS-related cutaneous Kaposi's sarcoma: failure of treatment with human chorionic gonadotropin.
Journal of chemotherapy (Florence, Italy) 1999;11(1):78-9.
1999: Polyzos A; Tsavaris N; Kosmas C; Giannikos L; Katsikas M; Kalahanis N; Karatzas G; Christodoulou K; Giannakopoulos K; Stamatiadis D; Katsilambros N
A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian cancer.
Oncology 1999;56(4):291-6.
1998: Koufos C; Tsavaris N; Travlou A
Unusual development of an abdominal neoplasm in a patient with Maffucci's syndrome.
Panminerva medica 1998;40(4):338-42.
1998: Tsavaris N; Fountzilas G; Mylonakis N; Athanassiadis A; Kosmas C; Karakousis C; Bacoyiannis C; Kosmidis P
A randomized comparative study of antiemetic prophylaxis with ondansentron in a single 32-mg loading dose versus 8 mg every 6 h in patients undergoing cisplatin-based chemotherapy.
Oncology 1998;55(6):513-6.
1998: Tsavaris N; Mylonakis N; Bacoyiannis C; Kosmas C; Kalergis G; Iakovidis V; Tzaninis D; Kosmidis P
Factors that influence the antiemetic activity of metoclopramide to cisplatin based chemotherapy.
Oncology reports 1998;5(5):1147-55.
1998: Tsavaris N; Tentas K; Tzivras M; Kosmas C; Kalachanis N; Katsikas M; Dimitrakopoulos A; Papastratis G; Macheras A; Karatzas G; Sechas M
Combined epirubicin, 5-fluorouracil and folinic acid vs no treatment for patients with advanced pancreatic cancer: a prospective comparative study.
Journal of chemotherapy (Florence, Italy) 1998;10(4):331-7.
1998: Tsavaris N; Tsigalacis D; Kosmas C; Koufos C; Vaiopoulos G; Tzivras M; Kouraklis G; Papadimas V; Georgoulis V; Archimandritis A; Sechas M
Preliminary evaluation of the potential prognostic value of serum levels of immunoglobulins (IgA, IgM, IgG, IgE) in patients with gastric cancer.
The International journal of biological markers 1998;13(2):87-91.
1998: Tsavaris N B; Pangalis G A
Neutrophil 5-nucleotidase reaction in chronic myelogenous leukemia, myelofibrosis with myeloid metaplasia, and polycythemia vera.
Annals of hematology 1998;76(1):1-5.
1998: Tsavaris N B; Kosmas C
Risk of severe acute hypersensitivity reactions after rapid paclitaxel infusion of less than 1-h duration.
Cancer chemotherapy and pharmacology 1998;42(6):509-11.
1997: Tsavaris N; Primikirios N; Mylonakis N; Varouchakis G; Dosios T; Pavlidis N; Skarlos D; Tasopoulos T; Dritsas J; Kosmidis P
Combination chemotherapy with cisplatin and/or doxorubicin in malignant mesothelioma. A retrospective study [corrected from prospective].
Anticancer research 1997;17(5B):3799-802.
1997: Kosmidis P A; Bacoyiannis C; Fountzilas G; Aravantinos G; Tsavaris N; Milathianakis C; Skarlos D
5-Fluorouracil, interferon-alpha-2b and cisplatin (FAP) for advanced urothelial cancer. A phase II study. Hellenic Co-operative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(4):373-8.
1997: Polyzos A; Tsavaris N; Veslemes M; Dardoufas K; Dosios T; Kosmas C
Chemotherapy of non small cell lung cancer. A prospectively randomized study of cisplatin-etoposide versus cisplatin-mitomycin-vinblastine.
Journal of chemotherapy (Florence, Italy) 1997;9(2):102-5.
1997: Tsavaris N; Polyzos A; Kosmas C; Giannikos L; Gogas J
A feasibility study of 1-h paclitaxel infusion in patients with solid tumors.
Cancer chemotherapy and pharmacology 1997;40(4):353-7.
1996: Tsavaris N; Baxevanis C; Kosmidis P; Papamichael M
The prognostic significance of immune changes in patients with renal cancer, melanoma and colorectal cancer, treated with interferon alpha 2b.
Cancer immunology, immunotherapy : CII 1996;43(2):94-102.
1996: Kosmidis P A; Tsavaris N; Skarlos D; Theocharis D; Samantas E; Pavlidis N; Briassoulis E; Fountzilas G
Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2682-7.
1996: Tsavaris N B; Tentas K; Kosmidis P; Mylonakis N; Sakelaropoulos N; Kosmas C; Lisaios B; Soumilas A; Mandrekois D; Tsetis A; Klonaris C
5-Fluorouracil, epirubicin, and mitomycin C versus 5-fluorouracil, epirubicin, mitomycin C, and leucovorin in advanced gastric carcinoma. A randomized trial.
American journal of clinical oncology 1996;19(5):517-21.
1996: Kosmopoulou O; Foukaneli T; Tsavaris N; Agapitos E; Seretis A; Kordossis T
Lung squamous cell carcinoma presenting with brain metastases in an HIV-positive patient.
Lung cancer (Amsterdam, Netherlands) 1996;15(2):245-9.
1996: Bafaloukos D; Pavlidis N; Fountzilas G; Skarlos D; Klouvas G; Makrantonakis P; Giannakakis T; Tsavaris N; Kosmidis P
Recombinant interferon ALFA-2A in combination with carboplatin, vinblastine, and bleomycin in the treatment of advanced malignant melanoma.
American journal of clinical oncology 1996;19(3):296-300.
1996: Tsavaris N; Tentas K; Kosmidis P; Mylonakis N; Sakelaropoulos N; Kosmas C; Lisaios B; Soumilas A; Mandrekas D; Tsetis A; Klonaris C
A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancer.
Chemotherapy 1996;42(3):220-6.
1996: Fountzilas G; Polichronis A; Katsohis K; Gennatas K; Toussis D; Skarlos D; Kosmidis P; Vassilaros S; Semoglou C; Giannakakis T; Fahantidis E; Klouvas G; Tsavaris N; Konstantaras C; Makrantonakis P; Kolotas C; Zamboglou N; Tsiliakos S; Hainoglou D; Mylonakis N; Pavlidis N
Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group Study.
Oncology 1996;53(2):137-46.
1996: Polyzos A; Tsavaris N; Giannopoulos A; Bacoyiannis C; Papadimas V; Kalahanis N; Karatzas G; Kosmas C; Sakelaropoulos N; Archimandritis A; Papachristodoulou A; Kosmidis P
Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
Cancer chemotherapy and pharmacology 1996;38(3):292-7.
1995: Tsavaris N; Tentas K; Bacoyiannis C; Katsikas M; Sakelaropoulos N; Kosmas C; Daliani D; Kosmidis P
5-Fluorouracil, folinic acid and cisplatin in advanced colorectal cancer: a pilot study.
Anti-cancer drugs 1995;6(4):599-603.
1995: Tsavaris N; Mylonakis N; Bacoyiannis C; Karvounis N; Charalambidis G; Pagou M; Lioni A; Daliani D; Kosmidis P
Efficacy of ondansetron treatment with different timing schedules: a randomized double-blind study.
Oncology 1995;52(4):315-8.
1995: Tsavaris N; Foutzilas G; Markantonakis P; Mylonakis N; Bacoyannis C; Zisiadis A; Basdanis G; Karvounis N; Sobolos K; Kosmidis P
A comparative study with two administration schedules of leucovorin and 5-fluorouracil in advanced colorectal cancer.
Journal of chemotherapy (Florence, Italy) 1995;7(1):71-7.
1995: Tsavaris N B; Tsaroucha-Noutsou E; Karvounis N; Bacoyannis C; Pagou M; Kosmidis P
Comparison of different schedules of ondansetron (GR 38032F) administration during cisplatin-based chemotherapy: a randomized trial.
Chemotherapy 1995;41(1):70-6.
1995: Tsavaris N; Charalambidis G; Ganas N; Pagou M; Karabellis A; Mylonakis N; Benou N; Tsikalakis D; Kosmidis P
Ondansetron versus metoclopramide as antiemetic treatment during cisplatin-based chemotherapy. A prospective study with special regard to regard to electrolyte imbalance.
Acta oncologica (Stockholm, Sweden) 1995;34(2):243-6.
1995: Tsavaris N; Baxevanis K; Kosmidis P; Papamichael M
The prognostic significance of immune changes in patients with renal cancer and melanoma treated with interferon-alpha 2b.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1995;16(6):365-73.
1994: Tsavaris N; Charalambidis G; Pagou M; Karabelis A; Mylonakis N; Bacoyiannis C; Kosmidis P
Comparison of ondansentron (GR 38032F) versus ondansentron plus alprazolam as antiemetic prophylaxis during cisplatin-containing chemotherapy.
American journal of clinical oncology 1994;17(6):516-21.
1994: Tsavaris N; Mylonakis N; Karvounis N; Bacoyiannis C; Briasoulis E; Skarlos D; Pavlidis N; Stamatelos G; Kosmidis P
Combination chemotherapy with cisplatin-vinblastine in malignant mesothelioma.
Lung cancer (Amsterdam, Netherlands) 1994;11(3-4):299-303.
1994: Tsavaris N; Mylonakis N; Bacoyiannis C; Katsikas M; Lioni A; Kosmidis P
Comparison of ondansentron versus ondansentron plus methylprednisolone as antiemetic prophylaxis during cisplatin-containing chemotherapy.
Journal of pain and symptom management 1994;9(4):254-8.
1994: Kordossis T; Kosmopoulou O; Zagoreos J; Dossios T; Deladetsima I; Tsavaris N; Sipsas N; Stratigos J; Papavassiliou K
Malignant mesothelioma in an HIV-positive patient.
AIDS (London, England) 1994;8(3):394-5.
1993: Tsavaris N; Mylonakis N; Bacoyiannis C; Tsoutsos H; Karabelis A; Kosmidis P
Treatment of renal cell carcinoma with escalating doses of alpha-interferon.
Chemotherapy 1993;39(5):361-6.
1993: Tsavaris N; Vonorta K; Tsoutsos H; Kozatsani-Halividi D; Mylonakis N; Papagrigoriou D; Koutsiouba-Kazakou P; Kosmidis P
Carcinoembryonic antigen (CEA), alpha-fetoprotein, CA 19.9 and CA 125 in advanced colorectal cancer (ACC).
The International journal of biological markers 1993;8(2):88-93.
1993: Skarlos D V; Fountzilas G; Pavlidis N; Beer M; Makrantonakis P; Aravantinos G; Pantelakos P; Tsavaris N; Karpasitis N; Kosmidis P
Megestrol acetate in cancer patients with anorexia and weight loss. A Hellenic Co-operative Oncology Group (HeCOG) study.
Acta oncologica (Stockholm, Sweden) 1993;32(1):37-41.
1992: Kosmidis P A; Baxevanis C N; Tsavaris N; Papanastasiou M; Anastasopoulos E; Bacoyiannis C; Mylonakis N; Karvounis N; Bafaloukos D; Karabelis A
The prognostic significance of immune changes in patients with renal cell carcinoma treated with interferon alfa-2b.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(7):1153-7.
1992: Tsavaris N; Tsigalakis D; Bobota A; Tsoutsos E; Sarafidou M; Papazachariou M; Komitsopoulou P; Kosmidis P
Prognostic value of serum levels of immunoglobulins (IgA, IgM, IgG, IgE) in patients with colorectal cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1992;18(1):31-6.
1992: Mylonakis N; Tsavaris N; Bacoyiannis C; Karvounis N; Kakolyris S; Karabelis A; Beer M; Kosmidis P
A randomized prospective study of cisplatin and vinblastine versus cisplatin, vinblastine and mitomycin in advanced non-small cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(2):127-30.
1992: Tsavaris N B; Komitsopoulou P; Karagiaouris P; Loukatou P; Tzannou I; Mylonakis N; Kosmidis P
Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach.
Cancer chemotherapy and pharmacology 1992;30(4):330-3.
1992: Tsavaris N; Tzannou I; Karvounis N; Kosmidis P
Continuous 24-hour infusion of folinic acid does not increase the response rate of 5-fluorouracil but only the toxicity.
Oncology 1992;49(2):154-6.
1992: Tsavaris N; Tsaroucha-Noutsou E; Bacoyannis C; Mylonakis N; Valilis P; Kozatsani-Halividi D; Tsoutsos H; Droufakou S; Kosmidis P
Antiemetic efficacy of high-dose metoclopramide and dexamethasone in patients receiving cisplatin chemotherapy: a randomized trial.
Oncology 1992;49(6):479-83.
1991: Tsavaris N; Zinelis A; Tsoutsos H; Kosmidis P
The response of paraneoplastic fever of lymphomas and solid tumours to the administration of naproxen.
Journal of internal medicine 1991;230(6):549-50.
1991: Tsavaris N; Zamanis N; Zinelis A; Tsoutsos E; Mylonakis N; Bacoyannis C; Valilis P; Sarafidou M; Kosmidis P
Diphenhydramine for nausea and vomiting related to cancer chemotherapy with cisplatin.
Journal of pain and symptom management 1991;6(8):461-5.
1991: Fountzilas G; Skarlos D; Pavlidis N A; Makrantonakis P; Tsavaris N; Kalogera-Fountzila A; Giannakakis T; Beer M; Kosmidis P
High-dose epirubicin as a single agent in the treatment of patients with advanced breast cancer. A Hellenic Co-operative Oncology Group study.
Tumori 1991;77(3):232-6.
1991: Fountzilas G; Zisiadis A; Kosmidis P; Basdanis G; Makrantonakis P; Paspatis A; Tsavdaridis D; Tsavaris N; Aletras O; Tourkantonis A
High-dose leucovorin, fluorouracil and oral dipyridamole in the treatment of advanced colorectal cancer.
Anticancer research 1991;11(2):865-8.
1991: Tsavaris N; Tsoutsos H; Bacoyannis C; Mylonakis N; Karvounis N; Kozatsani-Halividi D; Tsaroucha-Noutsou E; Klinaki A; Kosmidis P
Antiemetic efficacy of alprazolam in carboplatin-induced emesis.
Chemotherapy 1991;37(5):364-70.
1991: Tsavaris N B; Komitsopoulou P; Tzannou I; Loucatou P; Tsaroucha-Noutsou A; Kilafis G; Kosmidis P
Decreased oral toxicity with the local use of allopurinol in patients who received high dose 5-fluorouracil.
Selective cancer therapeutics 1991;7(3):113-7.
1990: Tsavaris N; Zinelis A; Karabelis A; Beldecos D; Bacojanis C; Milonacis N; Karvounis N; Kosmidis P
A randomized trial of the effect of three non-steroid anti-inflammatory agents in ameliorating cancer-induced fever.
Journal of internal medicine 1990;228(5):451-5.
1990: Tsavaris N B; Karagiaouris P; Tzannou I; Komitsopoulou P; Bacoyiannis C; Karabellis A; Papanicolaou V; Mylonakis N; Karvounis N; Zoannou A
Conservative approach to the treatment of chemotherapy-induced extravasation.
The Journal of dermatologic surgery and oncology 1990;16(6):519-22.
1990: Tsavaris N; Zinelis A; Karvounis N; Beldecos D; Mylonacis N; Zamanis N; Bacoyannis C; Valilis P; Antonopoulos A; Kosmidis P
Multimodal biochemical modulation of 5-fluorouracil activity in advanced colorectal cancer with allopurinol, folinic acid and dipyridamol.
Journal of chemotherapy (Florence, Italy) 1990;2(2):123-6.
1990: Tsavaris N; Karagiaouris P; Vonorta K; Bacogianis H; Milonakis N; Karvounis N; Kakoliris S; Zepou E; Karabelis A; Papazahariou M
Concomitant administration of 4-hydroxypyrazolopyrimidine (allopurinol) and high-dose continuous infusion 5-fluorouracil.
Oncology 1990;47(1):70-4.
1990: Tsavaris N B; Papaioannou D; Beldecos D; Kakoliris S; Mylonakis N; Karvounis N; Komitsopoulou P; Karagiaouris P; Sarmas J; Tzannou I
Comparison of antiemetic activity of chloropromazine and high doses of metoclopramide in cisplatin-based chemotherapy.
Acta oncologica (Stockholm, Sweden) 1990;29(8):1005-9.
1990: Tsavaris N; Bacoyannis C; Milonakis N; Sarafidou M; Zamanis N; Magoulas D; Kosmidis P
Folinic acid plus high-dose 5-fluorouracil with allopurinol protection in the treatment of advanced colorectal carcinoma.
European journal of cancer (Oxford, England : 1990) 1990;26(10):1054-6.
1990: Tsavaris N B; Pangalis G A; Variami E; Karabelis A; Kosmidis P; Raptis S
Association of neutrophil alkaline phosphatase activity and glycosylated haemoglobin in diabetes mellitus.
Acta haematologica 1990;83(1):22-5.
1988: Tsavaris N B; Kosmidis P A; Delides G S; Delides A; Papaioanou D; Pavlakis E; Lissaios B; Zaharakis M
Correlation of histoenzymological studies with the response to chemotherapy and survival in breast cancer patients.
Cancer letters 1988;42(3):225-30.
1988: Tsavaris N; Caragiauris P; Kosmidis P
Reduction of oral toxicity of 5-fluorouracil by allopurinol mouthwashes.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1988;14(5):405-6.
1987: Kosmidis P A; Fountzilas G; Athanassiou A; Karabelis A; Mylonakis N; Tsavaris N; Karvounis N; Bacojiannis C
Combination chemotherapy with prednimustine, adriamycin, vincristine (VAP) in advanced breast cancer. A phase II study.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1987;6(6):393-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Nicolas Tsavaris

Research Profile (preview)

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Nicolas Tsavaris (preview)

All Publications